Prescribing postmenopausal hormone therapy to women in their 50s in the post-Women's Health Initiative era

Maturitas

Volumn 65, Issue 3, 2010, Pages 179-180

  Rossouw, Jacques E ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GESTAGEN;

BREAST CANCER; CANCER RISK; CARDIOVASCULAR RISK; EDITORIAL; ENDOMETRIUM CANCER; HORMONE SUBSTITUTION; HUMAN; ISCHEMIC HEART DISEASE; MENOPAUSAL SYNDROME; OBSERVATIONAL STUDY; OSTEOPOROSIS; POSTMENOPAUSE; PUBLICATION; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; STROKE; TREATMENT DURATION; TREATMENT INDICATION; VENOUS THROMBOEMBOLISM;

BREAST NEOPLASMS; CARDIOVASCULAR DISEASES; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MIDDLE AGED; POSTMENOPAUSE;

EID: 76349096684     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2009.11.012     Document Type: Editorial

References (6)

1. Hulley S., Grady D., Bush T., et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 280 (1998) 605-613
2. Rossouw J.E., Anderson G.L., Prentice R.L., et al. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin for healthy postmenopausal women. JAMA 288 (2002) 321-333
3. Anderson G.L., Limacher M., Assaf A.R., et al. Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with a hysterectomy. JAMA 291 (2004) 1701-1712
4. Prentice R.L., Manson J.E., Langer R.D., et al. Benefits and risks of postmenopausal hormone therapy when initiated soon after the menopause. Am J Epidemiol 170 (2009) 12-23
5. Hernan M.A., Alonso A., Logan R., et al. Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart disease. Epidemiology 19 (2008) 766-779
6. Rossouw J.E., Prentice R.L., Manson J.E., et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 297 (2007) 1465-1477